Healthy volunteers test two pill strengths for future cancer therapy
NCT ID NCT05391048
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 22 times
Summary
This study tested two different strengths (10 mg and 20 mg) of an experimental drug called IMP4297 in 36 healthy Chinese men. The goal was to see if the body processes both strengths the same way after a meal. This is a bioequivalence study, meaning it checks if the two versions are interchangeable, not whether the drug treats disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xuzhou Central Hospital
Xuzhou, Jiangsu, 221000, China
Conditions
Explore the condition pages connected to this study.